» Articles » PMID: 17383611

Synergistic Cooperation of Sall4 and Cyclin D1 in Transcriptional Repression

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2007 Mar 27
PMID 17383611
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Loss of function mutations in SALL4 cause Okihiro syndrome, an autosomal dominant disorder characterised by radial ray malformations associated with Duane anomaly. In zebrafish and mouse Sall4 interacts with TBX5 during limb and heart development and plays a crucial role for embryonic stem (ES) cell pluripotency. Here we report the nuclear interaction of murine Sall4 with Cyclin D1, one of the main regulators of G(1) to S phase transition in cell cycle, verified by yeast two-hybrid assay, co-immunoprecipitation and intracellular co-localisation. Furthermore, using luciferase reporter gene assays we demonstrate that Sall4 operates as a transcriptional repressor located to heterochromatin and that this activity is modulated by Cyclin D1.

Citing Articles

Sall4 regulates downstream patterning genes during limb regeneration.

Erickson J, Walker S, Arenas Gomez C, Echeverri K Dev Biol. 2024; 515:151-159.

PMID: 39067503 PMC: 11325254. DOI: 10.1016/j.ydbio.2024.07.015.


Zinc Finger Protein SALL4 Functions through an AT-Rich Motif to Regulate Gene Expression.

Kong N, Bassal M, Tan H, Kurland J, Yong K, Young J Cell Rep. 2021; 34(1):108574.

PMID: 33406418 PMC: 8197658. DOI: 10.1016/j.celrep.2020.108574.


The transcription factor Spalt and human homologue SALL4 induce cell invasion via the dMyc-JNK pathway in .

Sun J, Zhang J, Wang D, Shen J Biol Open. 2020; 9(3).

PMID: 32098783 PMC: 7104861. DOI: 10.1242/bio.048850.


SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes.

Hermosilla V, Salgado G, Riffo E, Escobar D, Hepp M, Farkas C Mol Oncol. 2018; 12(7):1026-1046.

PMID: 29689621 PMC: 6026872. DOI: 10.1002/1878-0261.12308.


SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway.

Liu C, Wu H, Li Y, Shen L, Yu R, Yin H J Neurooncol. 2017; 135(2):263-272.

PMID: 28887597 PMC: 5663806. DOI: 10.1007/s11060-017-2589-3.